Analysis by Deloitte indicates that use of cloud, AI, and wearable technologies in the plant has increased markedly in recent years, particularly since the COVID-19 pandemic disrupted normal operations.
And biopharma’s willingness to use digital technologies is feeding back through the supply chain, according to Jonathan Royce, CEO of purification resin developer Bio-Works.
Continue reading here: https://bit.ly/3NdH7oX
#BiotechPharma #Biotech #pharmaceutical #pharma #healthcare #medicine #BostonBioPharmaConsultants